The American people clearly spoke, and the drubbing Democrats received requires looking beyond just issue polls, voting patterns, campaign strategy, or get-out-the-vote tactics.
Turing Pharmaceuticals
Follow:
-
Pharma Fight in California: The Next Phase in Bernie’s Revolution Has Already Begun
Proposition 61 could be a watershed moment in American health care, reforming drug-purchasing and stopping price-gouging by Big Pharma.
-
Big Pharma Execs Express Worry About Presidential Candidates Demanding Reform
Responding to tough talk by presidential candidates about price gouging by drug companies, pharmaceutical executives have told investors that they are working actively to influence the political debate.
-
Martin Shkreli Is An Example Of Why We Need Publicly Funded Pharmaceutical Research
Facing national outrage, the 32-year-old CEO backed down from the 5000% price increase his company announced this week for the malaria and toxoplasmosis drug Daraprim, sparking an overdue debate about the outlandish cost of life-saving medicines.
